Fund Name | Location |
BCE Capital | Massachusetts, United States, Waltham |
Dorchester Capital | Oklahoma, Oklahoma City, United States |
Extreme Innovations | Canada, Ontario, Toronto |
FarSight Capital | - |
Genome Canada | Canada, Ontario, Ottawa |
Jinguang Zijin | China, Jiangsu, Nanjing |
Neste | Espoo, Finland, Uusimaa |
Persistent Energy Partners | New York, New York, United States |
The Royal Bank of Scotland | City of Edinburgh, Scotland, United Kingdom |
TMFOX VENTURE PARTNERS | China, Guangdong, Shenzhen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ReviR Therapeutics | $30M | 26 Jul 2024 | San Francisco, California, United States | ||
Leman Biotech | $7M | 18 Jun 2024 | Lausanne, Vaud, Switzerland | ||
Aoshixin | 18 Apr 2024 | Chengdu, Sichuan, China | |||
CytoCan Corp. | $1M | 07 Feb 2023 | Shangcheng, Shaanxi, China | ||
META Pharmaceuticals | $15M | 13 Jun 2022 | Shenzhen, Guangdong, China | ||
PhoreMost | $45M | 23 Mar 2021 | Cambridge, England, United Kingdom | ||
23 Mar 2020 | Zhejiang |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ReviR Therapeutics | $30M | 26 Jul 2024 | San Francisco, California, United States | ||
Leman Biotech | $7M | 18 Jun 2024 | Lausanne, Vaud, Switzerland | ||
Aoshixin | 18 Apr 2024 | Chengdu, Sichuan, China | |||
CytoCan Corp. | $1M | 07 Feb 2023 | Shangcheng, Shaanxi, China | ||
META Pharmaceuticals | $15M | 13 Jun 2022 | Shenzhen, Guangdong, China | ||
PhoreMost | $45M | 23 Mar 2021 | Cambridge, England, United Kingdom | ||
23 Mar 2020 | Zhejiang |